Growth factor release from tissue engineering scaffolds

被引:203
作者
Whitaker, MJ
Quirk, RA
Howdle, SM
Shakesheff, KM
机构
[1] Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England
[2] Univ Nottingham, Regentec Ltd, Nottingham NG7 2RD, England
[3] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England
关键词
D O I
10.1211/0022357011777963
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Synthetic scaffold materials are used in tissue engineering for a variety of applications, including physical supports for the creation of functional tissues, protective gels to aid in wound healing and to encapsulate cells for localized hormone-delivery therapies. In order to encourage successful tissue growth, these scaffold materials must incorporate vital growth factors that are released to control their development. A major challenge lies in the requirement for these growth factor delivery mechanisms to mimic the in-vivo release profiles of factors produced during natural tissue morphogenesis or repair. This review highlights some of the major strategies for creating scaffold constructs reported thus far, along with the approaches taken to incorporate growth factors within the materials and the benefits of combining tissue engineering and drug delivery expertise.
引用
收藏
页码:1427 / 1437
页数:11
相关论文
共 143 条
[1]   Biodegradable PLA-PGA polymers for tissue engineering in orthopaedics [J].
Agrawal, CM ;
Athanasiou, KA ;
Heckman, JD .
POROUS MATERIALS FOR TISSUE ENGINEERING, 1997, 250 :115-128
[2]   Intraarterial protein delivery via intimally-adherent bilayer hydrogels [J].
An, YJ ;
Hubbell, JA .
JOURNAL OF CONTROLLED RELEASE, 2000, 64 (1-3) :205-215
[3]   Issues and perspectives on the biocompatibility and immunotoxicity evaluation of implanted controlled release systems [J].
Anderson, JM ;
Langone, JJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (02) :107-113
[4]   Host response to tissue engineered devices [J].
Babensee, JE ;
Anderson, JM ;
McIntire, LV ;
Mikos, AG .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 33 (1-2) :111-139
[5]   Growth factor delivery for tissue engineering [J].
Babensee, JE ;
McIntire, LV ;
Mikos, AG .
PHARMACEUTICAL RESEARCH, 2000, 17 (05) :497-504
[6]   Materials for protein delivery in tissue engineering [J].
Baldwin, SP ;
Saltzman, WM .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 33 (1-2) :71-86
[7]   Development of microspheres for neurological disorders: From basics to clinical applications [J].
Benoit, JP ;
Faisant, N ;
Venier-Julienne, MC ;
Menei, P .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :285-296
[8]   Microspheres for protein delivery prepared from amphiphilic multiblock copolymers 1. Influence of preparation techniques on particle characteristics and protein delivery [J].
Bezemer, JM ;
Radersma, R ;
Grijpma, DW ;
Dijkstra, PJ ;
van Blitterswijk, CA ;
Feijen, J .
JOURNAL OF CONTROLLED RELEASE, 2000, 67 (2-3) :233-248
[9]  
BODEN SD, 1999, CLIN ORTHOP S, V367, pS84
[10]   Localized, direct plasmid gene delivery in vivo:: prolonged therapy results in reproducible tissue regeneration [J].
Bonadio, J ;
Smiley, E ;
Patil, P ;
Goldstein, S .
NATURE MEDICINE, 1999, 5 (07) :753-759